Prof. Dr. Jacob Schachter, Ph.D.
oncology, skin cancer
oncology, skin cancer
Overview
Country, City
Israel, Ramat Gan
Health facility
SHEBA Medical Center Ramat Gan
Medical unit
Department of skin cancer and melanoma
About the doctor
Skills & Expertise
melanoma
metastatic melanoma
cancer
immunotherapy
pembrolizumab
pelvic
children
skin
carcinoma
genital tract
tumor
trametinib
dabrafenib
skin cancer
lymphogranuloma venereum
chemotherapy
squamous cell
squamous cell carcinoma
oncology
metastases
tumor infiltrating lymphocytes
uveal melanoma
lymph node
cervical neoplasia
sentinel node
melanoma cell
nk cells
ceacam1 melanoma
inflammation
breast cancer
cervix
lung cancer
skin barrier function
metastatic uveal melanoma
laryngeal cancer
skinrelated inflammatory
breast papillomas
cervical atypia
prostate tumors
mutationpositive melanoma
infection tumor
mucosal melanoma
solid tumors
genitalium
neck
cervical dysplasia
cervical cancer
colorectal cancer
mutated metastatic melanoma
metastatic breast cancer
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine at the Hebrew University of Jerusalem
- Obtaining a license for medical practice
- Residency at the Rabin Medical Center, Belinson campus
- 1986 Residency at the National Institutes of Health – National Cancer Institute
- Obtaining specialization in oncology
Experience
- Department of the intensive care unit at the Medical Center of Ichilov Sourasky
- Senior Consultant at the Department of oncology of the Assuta Hospital
- Deputy Director of the Department of skin cancer and melanoma at the SHEBA Medical Center Ramat Gan
- 2004 Chairman of the Department of skin cancer and melanoma at the SHEBA Medical Center Ramat Gan
- Founder of the Lemelbaum Institute of Immuno-oncology
- Professor at the Tel-Aviv University
Awards & Memberships
- Head of the forum of the Israeli Melanoma Society
- Member of the European Organization for the Research and Treatment of Cancer
- Member of the Israeli Society for Oncology and Clinical Radiotherapy
- Member of the Society for Biotherapy
- Member of the early clinical study group
Languages
English
Hebrew
Publications
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.
9 November, 2023
Vitiligo induced by dupilumab treatment: A case series.
November, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.
31 August, 2023
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. Jacob Schachter, Ph.D.?
The primary specialization of the doctor is oncology, skin cancer.
What is the experience of the specialist?
Prof. Dr. Jacob Schachter, Ph.D. has been practicing for more than 38 years.
Prof. Dr. Jacob Schachter, Ph.D.
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. Jacob Schachter, Ph.D.